In a report released today, William Katz from TD Cowen maintained a Hold rating on TPG (TPG – Research Report), with a price target of $65.00.

TD Cowen analyst Dan Brennan lowered the firm’s price target on NeoGenomics (NEO) to $19 from $20 and keeps a Buy rating on the shares. The ...

TD Cowen reiterated its Buy rating on Apollo Global Management (NYSE:APO) shares, maintaining a price target of $214.00.

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that members of the executive team are scheduled to participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on Tuesday, ...

TD Cowen assumed coverage on shares of Ermenegildo Zegna (NYSE:ZGN – Free Report) in a report published on Tuesday morning, Marketbeat reports. The brokerage issued a hold rating and a $10.00 target ...

Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. Olema is advancing ...

CNBC’s Eamon Javers and TD Cowen’s Roman Schweizer, join 'The Exchange' to discuss Trump's comments on halving defense ...

Rion Aesthetics, a company at the forefront of exosome technology in the aesthetics industry, today announced its ...

To access the live webcast of the panel presentation please visit the Events and Presentations page within the Ardelyx website at https://ir.ardelyx.com/events-and-presentations. A replay of the panel ...